| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +27.5K | 2.7% | $43.12 | +$1.19M |
| Sells | 14 | -1.01M | 97.3% | $42.35 | -$42.7M |
| Net | -13 | -980K | -94.7% | -$41.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael Morrissey | President and CEO, Director | $130M | Nov 11, 2025 | ||
| David Edward Johnson | Director | $67.7M | +$1.19M | +1.79% | Nov 25, 2025 |
| Stelios Papadopoulos | Director | $51.8M | -$5.97M | -10.3% | Nov 12, 2025 |
| Christopher J. Senner | EVP and CFO | $44.6M | -$5.66M | -11.3% | May 15, 2025 |
| Jeffrey Hessekiel | EVP & General Counsel | $32.1M | -$1.15M | -3.48% | May 15, 2025 |
| Dana Aftab | EVP, Research and Development | $25.2M | -$3.11M | -11% | Nov 21, 2025 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | $21.2M | -$3.31M | -13.5% | May 15, 2025 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | $16.1M | Jul 26, 2021 | ||
| Patrick J. Haley | EVP, Commercial | $15.9M | -$13.4M | -45.7% | Nov 20, 2025 |
| Jack L. Wyszomierski | Director | $15.5M | -$656K | -4.07% | Jun 3, 2025 |
| Peter Lamb | EVP, Scientific Strategy & CSO | $9.79M | Dec 15, 2022 | ||
| Lance Willsey | Director | $9.7M | May 26, 2022 | ||
| Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | $7.03M | Apr 3, 2023 | ||
| George Poste | Director | $6.47M | -$1.5M | -18.8% | May 29, 2025 |
| Charles Cohen | Director | $5.98M | Dec 31, 2021 | ||
| Brenda Hefti | SVP and General Counsel | $3.74M | Nov 7, 2025 | ||
| Maria C. Freire | Director | $3.65M | -$1.54M | -29.7% | May 29, 2025 |
| Vincent T. Marchesi | Director | $2.15M | May 26, 2022 | ||
| Bob Oliver | Director | $1.65M | -$695K | -29.7% | Nov 17, 2025 |
| Tomas J. Heyman | Director | $1.53M | -$201K | -11.6% | May 29, 2025 |
| Jacqueline Wright | Director | $1.18M | Jun 1, 2023 | ||
| Sue Gail Eckhardt | Director | $934K | -$1.21M | -56.5% | Jun 2, 2025 |
| Mary C. Beckerle | Director | $896K | -$1.46M | -61.9% | Nov 11, 2025 |
| Alan M. Garber | Director | $857K | Mar 21, 2024 | ||
| Julie Smith | Director | $745K | -$2.8M | -79% | May 29, 2025 |
| Carl B. Feldbaum | Director | $428K | Feb 9, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|